Les Laboratoires SERVIER

Type: Company
Name: Les Laboratoires SERVIER
First reported 6 hours ago - Updated 6 hours ago - 1 reports

Amgen Drug Wins Fast-Track Status

The U.S. Food and Drug Administration has granted fast-track designation for ivabradine, a heart drug licensed for sale by Amgen Inc. in Thousand Oaks.Ivabradine is an oral drug that inhibits electric signals in the heart, thus reducing the long-term ... [Published Los Angeles Business Journal - 6 hours ago]
First reported 17 hours ago - Updated 12 hours ago - 2 reports

Ivabradine Fast Tracked for Chronic HF

The U.S. Food and Drug Administration (FDA) has granted fast track designation for investigational ivabradine for patients with chronic heart failure (HF). Ivabradine is an oral drug that inhibits the If current (“funny” current) in the sinoatrial node, ... [Published Drug Discovery and Development - 12 hours ago]
First reported 18 hours ago - Updated 13 hours ago - 1 reports

Cohen’s Point72 Asset Management buys a stake in MacroGenics

Steven Cohen's Point72 Asset Management updates its portfolio (Part 3 of 5)( Continued from Part 2 )Point72 Asset Management and MacrogenicsSteven Cohen’s Point72 Asset Management, which was earlier known as SAC Capital, revealed a 6.6% stake, representing ... [Published Yahoo! Finance - 18 hours ago]
First reported Apr 17 2014 - Updated Apr 18 2014 - 1 reports

BBC Takes Aim at GSK Corruption

GlaxoSmithKline’s legal wrangle concerning corrupt practices in Poland was one target of a pharma expose by the BBC’s flagship current affairs show Panorama this week.The program featured an interview with a former GSK sales rep based in Lodz, who said ... [Published Pharmaceutical Executive - Apr 17 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 7 reports

Jacques Servier, founder and president of Lab Servier, dies aged 92

French independent drugmaker Laboratories Servier announced that its founder and president, Jacques Servier, has died at the age of 92.The spirit, the motivation and the mission of this exceptional personality, whose whole life revolved around the research ... [Published Pharma Letter - Apr 17 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

Servier - cretins in suits are sacking the brains

Major purge of scientific talent by inept, money-orientated, scumbags. God help you if you are intelligent. By the end of this year, Servier will have no science infrastructure in-house. Instead, the business arseholes want to contract everything out ... [Published BioFind - Apr 15 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

Polyhedra appoints Steve Hobbs chief business development officer

The Polyhedra Group has appointed Steve Hobbs as chief business development officer.He joins the group, which produces secure codes for pharmaceutical packs which patients and healthcare professionals can scan with their smartphone to access resources, ... [Published PMLive - Apr 15 2014]
First reported Apr 14 2014 - Updated Apr 14 2014 - 1 reports

CELLECTIS : Announces 2013 financial results

2013 Financial Statements• Operating revenue decreased by 21% in comparison with 2012, directly impacted by the brutal collapse of the tools and services market in 2013.• The operating loss mainly corresponds to an expense structure (prior to restructuring) ... [Published 4 Traders - Apr 14 2014]
First reported Apr 12 2014 - Updated Apr 12 2014 - 1 reports

Galapagos unlocks partial milestone in Servier alliance

MECHELEN, Belgium—Galapagos NV recently announced that it has received €2 million (approximately $2.7 million) as a partial milestone in its osteoarthritis alliance with Servier, which was established in July 2010. Per the terms of the agreement, Galapagos ... [Published Drug Discovery News - Apr 12 2014]
First reported Apr 03 2014 - Updated Apr 03 2014 - 1 reports

TGA slaps new restrictions on osteoporosis drug

Strontium ranelate should be restricted to a last-line therapy for osteoporosis and strictly avoided in patients with heart disease, the TGA has formally advised Australian doctors.The changes to the drug's product information follow a recent European ... [Published Australian Doctor - Apr 03 2014]
First reported Mar 26 2014 - Updated Mar 26 2014 - 1 reports

Servier inaugurates its subsidiary in Colombia

Servier, the leading independent French pharmaceutical group, has inaugurated its new subsidiary in Latin America, Servier Colombia, in the presence of the French Ambassador, Mr Jean-Marc Laforêt, and representatives of various Colombian public and private ... [Published PharmiWeb - Mar 26 2014]
First reported Mar 21 2014 - Updated Mar 21 2014 - 1 reports

MINISTRY OF NATIONAL ECONOMY OF HUNGARY : Strategic Partnership Agreement concluded with Servier Hungary Ltd

The Government concluded a Strategic Partnership Agreement with the French pharmaceutical company Servier Hungary which was signed by Minister for National Economy Mihály Varga and Servier CEO Michel Eschenbrenner at the company's pharmaceutical chemistry ... [Published 4 Traders - Mar 21 2014]

Quotes

treatment. In contrast, their study focuses on biomarkers and identifies "for the first time potential biomarkers that predict whether a patient will be a"
The analysts wrote, "Vernalis is well positioned to continue advancing all three elements of its business (commercial development, research) during 2014. The first US prescription (Rx) cough cold NDA filing is on track for mid-year, with proof of concept (PoC) for the four other products potentially being achieved by year-end. Key data on two in-house novel chemical entities may result in new licensing deals, and further progress in existing research collaborations is expected (including Phase I start for a Servier cancer drug) with milestone potential."
...Its drilling services continue to be distinctive, operating in many of the oil and gas industry "s "hotspots", frequently in synergy with its onshore and offshore activities. Saipem is a global contractor, with strong local presence in strategic and emerging areas such as West Africa, North Africa, FSU, Central Asia, Middle East, and South East Asia. Saipem is a truly international company. Along with its strong European content, the major part of its human resource base comes from developing Countries. Saipem employs over 40,000 people comprising more than 100 nationalities. In addition to the strong local content of its people, it employs large numbers of people from the most cost-effective developing countries on its vessels and sites, and has sizeable service bases in India, Croatia, Romania and Indonesia. Its clients and people - in particular their health and safety - are the primary focus of all Saipem activity. Saipem has a distinctive Health & Safety Environment Management System and its Quality Management System has been granted ISO 9001:2000 certification by Lloyd's Register Certification."
"It should also not be used in patients who are temporarily or permanently immobilised. Protos should be used with caution in patients with risk factors for cardiovascular events or venous thrombosis: hypertension, diabetes, smoking, hyperlipidaemia."

More Content

All (114) | News (96) | Reports (0) | Blogs (8) | Audio/Video (0) | Fact Sheets (2) | Press Releases (6)
sort by: Date | Relevance
Amgen Drug Wins Fast-Track Status [Published Los Angeles Business Journal - 6 hours ago]
Ivabradine Fast Tracked for Chronic HF [Published Drug Discovery and Development - 12 hours ago]
Asset Purchase Terms and Agreements in Pharma, ... [Published SBWire - 16 hours ago]
Recent Study: Personalized Medicine Partnering ... [Published Digital Journal - 16 hours ago]
Amgen's Heart Failure Drug Ivabradine Wins Fast... [Published BioSpace - 17 hours ago]
Cohen’s Point72 Asset Management buys a stake i... [Published Yahoo! Finance - 18 hours ago]
FDA Grants Fast Track Status To Amgen Heart Fai... [Published Forbes.com - Apr 17 2014]
Jacques Servier, founder and president of Lab S... [Published Pharma Letter - Apr 17 2014]
Founder of scandal-hit drugmaker Servier dies a... [Published DailyMe.Com - Apr 17 2014]
Founder of Servier dies [Published Wicklownews.net - Apr 17 2014]
GlaxoSmithKline and Galapagos succeed in psoria... [Published FierceBiotech - Apr 17 2014]
BBC Takes Aim at GSK Corruption [Published Pharmaceutical Executive - Apr 17 2014]
Founder of scandal-hit drugmaker Servier dies a... [Published NewsRT.co.uk - Apr 17 2014]
Founder of scandal-hit drugmaker Servier dies a... [Published Yahoo! Health News - Apr 17 2014]
Founder of scandal-hit drugmaker Servier dies a... [Published TrustMedia - Apr 17 2014]
Mediator drug scandal boss Jacques Servier dies... [Published EuroNews - Apr 17 2014]
BioInvent: BioInvent's Rights Issue Oversubscri... [Published FinanzNachrichten.de - Apr 17 2014]
New Market Research Report: Alzheimer's Disease... [Published SBWire - Apr 15 2014]
Servier - cretins in suits are sacking the brains [Published BioFind - Apr 15 2014]
Can Biomarkers Predict BP Response with Renal D... [Published Diabetes Care - Apr 15 2014]
Survey: Ivabradine Set to Become ‘Gold Standard... [Published P&T Community - Apr 15 2014]
BioInvent: Information Regarding on-Going New S... [Published FinanzNachrichten.de - Apr 15 2014]
Polyhedra appoints Steve Hobbs chief business d... [Published PMLive - Apr 15 2014]
CELLECTIS : Announces 2013 financial results [Published 4 Traders - Apr 14 2014]
Vernalis plc Given Positive Rating by Edison Gr... [Published American Banking News - Apr 14 2014]
Galapagos unlocks partial milestone in Servier ... [Published Drug Discovery News - Apr 12 2014]
Drug Provides Health Benefits to Diabetics with... [Published Newswise - Apr 10 2014]
Spironolactone for Heart Failure with Preserved... [Published New England Journal of Medicine - Apr 10 2014]
Vmware & Storage Administrator - Senior [Published IT Next - Apr 07 2014]
Industry and trade [Published The Lawyer - Apr 04 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Founder of scandal-hit drugmaker Servier dies a... [Published Yahoo! Health News - Apr 17 2014]
Jacques Servier, founder and president of France's second-largest drugmaker, has died before his trial over Mediator, a weight-loss pill at the center of the country's biggest public health scandal in years. Servier died of old age, a com... ...
Pharmacy News Test [Published Rx Times Pharmacy Magazine - Feb 17 2014]
Cellectis and Servier announce collaboration in allogeneic cell therapy: UCART19 to treat leukemia and 5 product candidates targeting solid tumors PARIS–(BUSINESS WIRE)–Cellectis and Servier announce collaboration in allogeneic cell therapy: UCART19 to ...
Cellectis and Servier announce collaboration in... [Published EON Science - Feb 17 2014]
PARIS--(EON: Enhanced Online News)--Cellectis and Servier announce collaboration in allogeneic cell therapy: UCART19 to treat leukemia and 5 product candidates targeting solid tumors ...
Cellectis and Servier announce collaboration in... [Published Business Wire Science: Science News - Feb 17 2014]
PARIS--(BUSINESS WIRE)--Cellectis and Servier announce collaboration in allogeneic cell therapy: UCART19 to treat leukemia and 5 product candidates targeting solid tumors ...
Cellectis and Servier announce collaboration in... [Published Business Wire Health News - Feb 17 2014]
PARIS--(BUSINESS WIRE)--Cellectis and Servier announce collaboration in allogeneic cell therapy: UCART19 to treat leukemia and 5 product candidates targeting solid tumors ...
1 2

Press Releases

sort by: Date | Relevance
Galapagos receives EU2 million from osteoarthri... [Published GlobeNewswire: Acquisitions News - Mar 07 2014]
Celladon Announces Option Agreement With Servier [Published GlobeNewswire: Acquisitions News - Feb 24 2014]
MacroGenics Achieves Milestone as Servier Exerc... [Published GlobeNewswire: Acquisitions News - Feb 05 2014]
Avalancha de fracturas de caderas afectará a As... [Published PR Newswire - Dec 12 2013]
Avalanche de fraturas de quadril vai atingir a ... [Published PR Newswire - Dec 12 2013]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.